China Pharma Holdings, Inc.
CPHI- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106644
No open-market purchases or sales by China Pharma Holdings, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $134.5K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding China Pharma Holdings, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 25.8K | 203.8K | +178.0K (+690.9%) |
| Value | $15.7K | $134.5K | +$118.8K (+755.8%) |
New holders (3)
Institutions that held China Pharma Holdings, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 35,666 | $23.5K | 0.00% |
| Jane Street Group, LLC | 13,886 | $9.17K | 0.00% |
| Ground Swell Capital, LLC | 10,610 | $7.00K | 0.01% |
Sold out (1)
Institutions that held China Pharma Holdings, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Citigroup Inc | 996 | $608 |